LITTLE FALLS, N.J.,
Nov. 6, 2013 /PRNewswire/ --
CANTEL MEDICAL CORP. (NYSE: CMN), has further enhanced its
leading endoscopy product portfolio with the acquisition of Jet
Prep Ltd. Based in Herzliya, Israel, Jet Prep Ltd. is the developer of the
Jet Prep Flushing Device, a novel single-use irrigation and
aspiration catheter to improve visualization during colonoscopy
procedures. The Jet Prep Flushing Device has FDA 510(k) and
CE Mark clearances and is ready for immediate commercialization by
our global endoscopy sales forces. The Jet Prep operation,
which will be integrated into our Medivators Endoscopy business,
will remain in Israel. Led by David
Nitsan, this group of R&D engineers will continue
working on new product development.
Don Byrne, President of
Medivators Endoscopy, stated, "This acquisition strengthens our
position as a leading provider of novel products and solutions for
GI endoscopy. The Jet Prep product is an important addition
to our growing portfolio of endoscopy products focused on infection
control and improving patient safety and outcomes."
Cantel Medical's Executive Vice President and COO, Jorgen Hansen, added, "We see the Jet Prep
product line as exactly the type of novel and highly differentiated
product that Medivators should be introducing to the market.
We know there is strong demand from physicians for a unique
solution to improving visualization and have high expectations for
its success in the GI endoscopy market. We remain confident
in the continued strong growth of our Medivators Endoscopy
business."
About Cantel Medical Corp.
Cantel Medical is a leading global company dedicated to
delivering innovative infection prevention and control products and
services for patients, caregivers, and other healthcare providers
which improve outcomes, enhance safety and help save lives.
Our products include specialized medical device reprocessing
systems for endoscopy and renal dialysis, advanced water
purification equipment, sterilants, disinfectants and cleaners,
sterility assurance monitoring products for hospitals and dental
clinics, disposable infection control products primarily for dental
and GI endoscopy markets, dialysate concentrates, hollow fiber
membrane filtration and separation products, and specialty
packaging for infectious and biological specimens. Additionally, we
provide technical service for our products. For further
information, visit the Cantel website at www.cantelmedical.com.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
SOURCE Cantel Medical Corp.